Evidence map›Paper›PMID 34088961›Full record

ArticleNPJ digital medicine2021

A vital sign-based prediction algorithm for differentiating COVID-19 versus seasonal influenza in hospitalized patients.

Naveena Yanamala, Nanda H Krishna, Quincy A Hathaway, Aditya Radhakrishnan, Srinidhi Sunkara, Heenaben Patel, Peter Farjo, Brijesh Patel, Partho P Sengupta

Open access · goldAbstract read
In one paragraph

Article in NPJ digital medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Introducing the Monitoring Equipment Mask Environment.Sensors (Basel, Switzerland) · 2022
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Naveena YanamalaDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA. naveena.yanamala.m@wvumedicine.org.ORCID http://orcid.org/0000-0002-4454-4240
Nanda H KrishnaDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.ORCID http://orcid.org/0000-0001-8036-2789
Quincy A HathawayDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.ORCID http://orcid.org/0000-0001-8226-2319
Aditya RadhakrishnanDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.
Srinidhi SunkaraDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.
Heenaben PatelDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.
Peter FarjoDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.
Brijesh PatelDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA.
Partho P SenguptaDivision of Cardiology, West Virginia University Medicine Heart & Vascular Institute, Morgantown, WV, USA. Partho.Sengupta@wvumedicine.org.
West Virginia University · USSoftware Engineering Institute · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
National Science Foundation (NSF) 1920920NIGMS NIH HHS U54 GM104942U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) 5U54GM104942-04
6 · The paper itself

Abstract

Patients with influenza and SARS-CoV2/Coronavirus disease 2019 (COVID-19) infections have a different clinical course and outcomes. We developed and validated a supervised machine learning pipeline to distinguish the two viral infections using the available vital signs and demographic dataset from the first hospital/emergency room encounters of 3883 patients who had confirmed diagnoses of influenza A/B, COVID-19 or negative laboratory test results. The models were able to achieve an area under the receiver operating characteristic curve (ROC AUC) of at least 97% using our multiclass classifier. The predictive models were externally validated on 15,697 encounters in 3125 patients available on TrinetX database that contains patient-level data from different healthcare organizations. The influenza vs COVID-19-positive model had an AUC of 98.8%, and 92.8% on the internal and external test sets, respectively. Our study illustrates the potentials of machine-learning models for accurately distinguishing the two viral infections. The code is made available at https://github.com/ynaveena/COVID-19-vs-Influenza and may have utility as a frontline diagnostic tool to aid healthcare workers in triaging patients once the two viral infections start cocirculating in the communities.

Identifiers

PMID34088961
PMCPMC8178379
OpenAlexW3164735068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.